Clinical trials of pharmacotherapy for spinal cord injury

Annals of the New York Academy of Sciences

Volumn 845, Issue , 1998, Pages 374-381

  Geisler, Fred H ^a  

^a Chicago Institute of Neurosurgery and Neuroresearch   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE GM1; METHYLPREDNISOLONE;

ADULT; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NERVE FUNCTION; NONHUMAN; RANDOMIZED CONTROLLED TRIAL; SPINAL CORD INJURY;

EID: 0031880309     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb09689.x     Document Type: Conference Paper

References (48)

1. STOVER, S. L. & P. R. FINE. 1986. Spinal Cord Injury: The Facts and Figures, National Spinal Cord Injury Statistical Center, The Univ. of Alabama at Birmingham. Birmingham.
2. NATIONAL CENTER FOR HEALTH STATISTICS. 1987. Advance Report of Final Mortality Statistics, 1985. U.S. Government Printing Office. Washington, D.C.
3. NATIONAL CENTER FOR HEALTH STATISTICS. 1986. Current Estimates from the National Health Interview Survey, United States, 1985. U.S. Government Printing Office. Washington, D.C.
4. BAKER, S. P., B. O'NEILL & M. J. GINSBURG. 1992. The Injury Fact Book. Oxford Univ. Press. New York.
5. BRACKEN, M. B., D. H. FREEMAN & K. HELLENBRAND. 1981. Incidence of acute traumatic hospitalized spinal cord injury in the United States, 1970-1977. Am J. Epidemiol. 113: 615-622.
6. GRIFFIN, M. R., J. L. OPITZ, L. T. KURLAND, M. J. EBERSOLD & W. M. O'FALLON. 1985. Traumatic spinal cord injury in Olmsteed County, Minnesota, 1935-1981. Am. J. Epidemiol. 121: 884-895.
7. KALSBEEK, W. D., R. L. MCLAURIN, B. S. H. HARRIS III & J. D. MILLER. 1989. The National Head and Spinal Cord Injury Survey: Major Findings. J. Neurosurg. 53: S19-S31.
8. KRAUS, J. F. 1987. Epidemiology of head injury. In Head Injury, P. R. Cooper, Ed. Williams & Wilkins. Baltimore, Md.
9. LE, C. T. & M. PRICE. 1981. Survival from spinal cord injury. J. Chronic Dis. 35: 487-492.
10. THOMAS, J. P. 1982. Introduction. In Spinal Cord Injury Statistics: Experience of the Regional Spinal Cord Injury Systems, J. S. Young, Ed.: 1-10. Good Samaritan Medical Center. Phoenix, Ariz.
11. MICHAELIS, L. S. & R. BRAAKMAN. 1976. Current terminology and classification of injuries of spine and spinal cord. In Handbook of Clinical Neurology, P. J. Vinken and G. W. Bruyn, Eds. Elsevier. Amsterdam.
12. GUTTMAN, L. 1976. Classification of spinal fractures. In Spinal Cord Injuries, Comprehensive Management and Research, L. Guttman, Ed. Blackwell. London.
13. FRANKEL, H. L., D. O. HANCOCK, G. HYSLOP, J. MELZAK, L. S. MICHAELIS, G. H. UNGAR, J. D. VERNON & J. J. WALSH. 1969. The value of postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia, Part I. Paraplegia 7: 179-192.
14. AMERICAN SPINAL INJURY ASSOCIATION. 1992. International Standards for Neurologic and Functional Classification of Spinal Cord Injury. Chicago, Ill.
15. BRACKEN, M. B., M. J. SHEPARD, K. G. HELLENBRAND, W. F. COLLINS, L. S. LEO, D. F. FREEMAN, F. C. WAGNER, E. S. FLAMM, H. M. EISENBERG & J. H. GOODMAN. 1985. Methylprednisolone and neurological function 1 year after spinal cord injury. Results of the National Acute Spinal Cord Injury Study. J. Neurosurg. 63: 704-713.
16. BRACKEN, M. B., W. F. COLLINS, D. F. FREEMAN, M. J. SHEPARD, F. W. WAGNER, R. M. SILTEN, K. G. HELLENBRAND, J. RANSOHOFF, W. E. HUNT & P. L. PEROT, JR. 1984. Efficacy of methylprednisolone in acute spinal cord injury. JAMA 251: 45-52.
17. ROSNER, M. J. & M. B. BRACKEN. 1991. National acute spinal cord injury study of methylprednisolone or naloxone (letter). Neurosurgery 28: 628-629.
18. BRACKEN, M. B., M. J. SHEPARD, W. F. COLLINS, JR., T. R. HOLFORD, D. S. BASKIN, H. M. EISENBERG, E. FLAMM, L. LEO-SUMMERS, J. C. MAROON & L. F. MARSHALL. 1992. Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-Year followup data. Results of the Second National Acute Spinal Cord Injury Study. J. Neurosurg. 76:23-31.
19. BRACKEN, M. B. 1991. Treatment of acute spinal cord injury with methylprednisolone. Results of a multicenter, randomized clinical trial. J. Neurotrauma 8: S47-S50.
20. BRACKEN, M. B., M. J. SHEPARD, W. F. COLLINS, T. R. HOLFORD, W. YOUNG, D. S. BASKIN, H. M. EISENBERG, E. FLAMM, L. LEO-SUMMERS & J. MAROON. 1990. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal cord injury. Results of the Second National Acute Spinal Cord Injury Study. N. Engl. J. Med. 322: 1405-1411.
21. BRACKEN, M. B. 1993. Pharmacological treatment of acute spinal cord injury: Current status and future projects. J. Emerg. Med. 11: S43-S48.
22. BRACKEN, M. B. & T. R. HOLFORD. 1993. Effects of timing of methylprednisolone or naloxone administration on recovery of segmental and long-tract neurological function in NASCIS2. J. Neurosurg. 79: 500-507.
23. BRACKEN, M. B., M. J. SHEPARD, T. R. HOLFORD, L. LEO-SUMMERS, E. F. ALDRICH, M. FAZL, M. FEHLINGS, D. L. HERR, P. W. HITCHON & L. F. MARSHALL. 1997. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA. 277: 1597-1604.
24. GEISLER, F. H. 1993. GM-1 ganglioside and motor recovery following human spinal cord injury. J. Emerg. Med. 11: S49-S55.
25. GEISLER, F. H., F. C. DORSEY & W. P. COLEMAN. 1993. Past and current clinical studies with GM-1 ganglioside in acute spinal cord injury. Ann. Emerg. Med. 22: 1041-1047.
26. GEISLER, F. H., F. C. DORSEY & W. P. COLEMAN. 1992. GM-1 ganglioside in human spinal cord injury. J. Neurotrauma 9: S407-S416.
27. GEISLER, F. H., F. C. DORSEY & W. P. COLEMAN. 1991. Correction: Recovery of motor function after spinal cord injury - A randomized, placebo-controlled trial with GM-1 ganglioside. N. Engl. J. Med. 325: 1659-1660.
28. GEISLER, F. H., F. C. DORSEY & W. P. COLEMAN. 1991. Recovery of motor function after spinal-cord injury - A randomized, placebo-controlled trial with GM-1 ganglioside. N. Engl. J. Med. 324: 1829-1838.
29. GEISLER, F. H., F. C. DORSEY & W. P. COLEMAN. 1992. GM-1 ganglioside in human spinal cord injury. J. Neurotrauma 9: S517-S530.
30. GEISLER, F. H. 1988. Acute management of cervical spinal cord injury. Md. Med. J. 37: 525-530.
31. STANDARDS FOR NEUROLOGICAL AND FUNCTIONAL CLASSIFICATION OF SPINAL CORD INJURY. 1994. Proceedings endorsed by the International Medical Society of Paraplegia Annual Meeting, Barcelona, Spain, September 7, 1992. American Spinal Injury Association, International Medical Society of Paraplegia.
32. LEDEEN, R. W. 1978. Ganglioside structures and distribution: Are they localized at the nerve ending? J. Supramol. Struct. 8: 1-17.
33. CECCARELLI, B., F. APORTI & M. FINESSO. 1976. Effects of brain gangliosides in functional recovery in experimental regeneration and reinnervation. Adv. Exp. Med. Biol. 71: 275-293.
34. EPSTEIN, N., D. C. HOOD & J. RANSOHOFF. 1981. Gastrointestinal bleeding in patients with spinal cord trauma. Effects of steroids, cimetidine, and mini-dose heparin. J. Neurosurg. 54: 16-20.
35. GORIO, A. 1988. Gangliosides as a possible treatment affecting neuronal repair process. Adv. Neurol. 47: 523-530.
36. GORIO, A. 1989. Ganglioside enhancement of neuronal differentiation, plasticity, and repair. CRC Crit. Rev. Clin. Neurobiol. 2: 241-296.
37. GORIO, A., G. FERRARI, M. FUSCO, D. JANIGRO, R. ZANONI & G. JONSSON. 1984. Gangliosides and their effects on rearranging peripheral and central neural pathways. Cent. Nerv. Syst. Trauma 1: 29-37.
38. LEDEEN, R. W. 1984. Biology of gangliosides: Neuritogenic and neuronotrophic properties. J. Neurosci. Res. 12: 147-159.
39. SABEL, B. A. 1988. Anatomic mechanisms whereby gangliosides induce brain repair: What do we really know? In Pharmacological Approaches to the Treatment of Brain and Spinal Cord Injury, D. Stein and B. Sabel, Eds. Plenum Press. New York.
40. SABEL, B. A., R. DEL MASTRO, G. L. DUNBAR & D. G. STEIN. 1987. Reduction of anterograde degeneration in brain damaged rats by GM-1-gangliosides. Neurosci. Lett. 77: 360-366.
41. SABEL, B. A. & D. G. STEIN. 1986. Pharmacological treatment of central nervous system injury. Nature 323: 493.
42. SABEL, B. A., G. L. DUNBAR & D. G. STEIN. 1984. Gangliosides minimize behavioral deficits and enhance structural repair after brain injury. J. Neurosci. Res. 12: 429-443.
43. SABEL, B. A., M. D. SLAVIN & D. G. STEIN. 1984. GM1 ganglioside treatment facilitates behavioral recovery from bilateral brain damage. Science 225: 340-342.
44. TOFFANO, G., G. SAVOINI, C. ALDINIO, G. VALENTI, R. DAL TOSO, A. LEON, L. CALZA, I. ZINI, L. F. IGNATI & K. FUXE. 1984. Effects of gangliosides on the functional recovery of damaged brain. Adv. Exp. Med. Biol. 174: 475-488.
45. WALKER, M. D. 1991. Acute spinal cord injury. N. Engl. J. Med. 324: 1885-1887.
46. RAMIREZ, J. J., B. FASS, S. E. KARPIAK & O. STEWARD. 1987. Ganglioside treatments reduce locomotor hyperactivity after bilateral lesions of the entorhinal cortex. Neurosci. Lett. 75: 283-287.
47. RAMIREZ, J. J., B. FASS, T. KILFOIL, B. HENSCHEL, W. GRONES & S. E. KARPIAK. 1987. Gangliosides induce enhancement of behavioral recovery after bilateral lesions of the entorhinal cortex. Brain Res. 414: 85-90.
48. BENZEL, E. C. & S. J. LARSON. 1987. Functional recovery after decompressive spine operation for cervical spine fractures. Neurosurgery 20: 742-746.